Senti Biosciences Inc (SNTI) Financials

$0.30

$-0.02 (-5.32%)

As on 09-Sep-2026 16:05EDT

Market cap

$10 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

5.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.06	0.02	--	1.98	4.29	2.29
Cost of Revenue	2.46	3.64	--	5.24	3.92	3.01
Gross Profit	-2.41	-3.62	--	1.98	4.29	2.29
Operating Expenses	55.01	60.11	61.04	94.71	74.92	42.74
Operating Profit (EBIT)	-56.52	-63.73	-61.04	-92.73	-70.63	-40.45
Other Income	--	--	--	--	10.72	--
Profit before Tax	-49.56	-61.44	-52.79	-83.41	-58.21	-55.32
Provision for Tax	--	--	--	9.51	-12.42	0.01
Profit after Tax (Net Income)	-49.56	-61.44	-52.79	-71.06	-45.79	-55.32
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-58.21	-55.32

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-3.40	5.59	25.65	66.91	127.26	60.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	20.74	31.66	59.05	39.90	35.48	21.78
Current Liabilities	15.77	13.97	13.15	12.67	18.05	14.54
Total Liabilities	48.87	51.22	97.84	119.48	180.79	96.70

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	20.10	27.95	38.88	48.28	78.21	37.96
Current Assets	13.01	23.27	58.96	71.20	102.58	58.75
Total Assets	48.87	51.22	97.84	119.48	180.79	96.70
Total Debt*	20.23	28.89	33.64	37.67	37.09	22.73
Net Current Assets	-2.76	9.30	45.82	58.53	84.53	45.65

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-43.44	-41.40	-52.40	-34.90	-34.64
Cash Flow from Investing Activities	--	-0.18	0.03	30.08	-81.96	-5.54
Cash from Financing Activities	--	11.76	53.73	0.78	118.55	68.44
Net Cash Inflow / Outflow	--	--	--	--	1.70	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.88	-2.73	-11.49	-1.59	-10.45	-12.67
Cash EPS ($)	--	-2.57	-10.21	-1.48	-9.55	-11.98
Adjusted Book Value ($)	--	0.25	5.58	1.50	29.04	13.83
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.93	-9.01	-1.17	-7.96	-7.93
Free Cash Flow per Share ($)	--	-1.94	-9.01	-1.44	-17.40	-9.20

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-131.04	-64.43	-52.84	-37.01	-287.80
ROE (%)	--	-393.35	-114.06	-73.19	-48.81	-6,652.92
ROA (%)	-77.81	-82.43	-48.58	-47.33	-33.00	-76.28
EBIT Margin (%)	-91,136.36	-279,263.64	--	-3,375.38	-1,647.90	-2,414.62
Net Margin (%)	-90,116.36	-279,263.64	--	-3,592.42	-305.19	-2,414.62
Cash Profit Margin (%)	-0.04	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-99.06	--	-1.00	-0.54	0.87	4.81
EBIT Growth (%)	-13.00	-1.17	9.05	5.47	-27.68	-124.02
Net Profit Growth (%)	-99.06	-16.38	25.71	-55.18	17.22	-178.52
EPS Growth (%)	81.34	0.76	-6.22	0.85	0.18	0.08
Book Value Growth (%)	-111.55	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.38	-0.31	-0.41	-0.13	-0.78
Price / Book Value	5.45	4.18	0.63	0.44	0.05	0.71
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.28	-0.62	-0.03	-0.51	0.83	-0.16
Close Price ($)	1.10	1.04	3.51	6.60	14.10	98.60
High Price ($)	2.88	5.10	16.94	21.10	100.00	105.40
Low Price ($)	0.77	1.04	1.52	2.70	12.00	95.80
Market Cap ($ Cr)	10.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	5.17	1.31	0.56	0.29	0.38
Short term debt to equity ratio	-2.20	0.95	0.19	0.06	0.02	0.03
Current Ratio	0.83	1.67	4.49	5.62	5.68	4.04
Quick Ratio	0.83	--	4.46	--	5.50	3.86
Interest Coverage	--	--	--	--	-18.02	-5,029.00

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	1,012.73	7,250.00	--	895.05	14.61	21.08
Asset Turnover	0.00	0.00	--	0.01	0.03	0.03
Receivable days	--	28,223.86	--	1,692.37	47.25	63.77
Inventory Days	--	33.64	--	229.08	274.50	159.45
Payable days	--	220.79	--	122.48	347.27	370.16
Cash Conversion Cycle	--	28,036.72	--	1,798.98	-25.52	-146.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.